Two-thirds of the world’s sickle cell cases are in Africa, making it the most prevalent genetically acquired disease in the region. In Zambia, 20-25% of the
In a country where about a quarter of the population carry the gene for the inherited blood disorder, more early diagnosis and treatment for children is saving lives
<p>Leukaemia trial shows 'exceptional' resultsPersonalised treatment for the most common form of adult leukaemia helps patients survive for longer and stay in remission, a phase III trial has found.</p>
<p>Adult patients were given a combination of cancer growth blocking drugs over varied durations depending on how rapidly their disease responded. </p>
<p>More than 19 in 20 patients were in remission three years after starting treatment - a significant improvement in progression-free and overall survival compared to standard treatment.</p>
<p>Study lead Professor Peter Hillmen said: “The results of the FLAIR Trial, led by the Leeds Cancer Research UK Clinical Trials Unit at the University of Leeds, are exceptional and herald a change in the way chronic lymphocytic leukaemia will be treated.”</p>